Pregabalin: the battle continues
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
22nd June 2017
Web Exclusives
Will there be a Brexit boom?
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
20th June 2017
The wearable revolution
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
16th June 2017
Why AI won't replace clinical researchers
How technology can help rather than hinder the human touch in clinical research
5th December 2016
Bribery: a bitter pill
What AstraZeneca's bribery scandal says about pharma's compliance policies
10th November 2016
Monsanto-Bayer: a raw deal?
How will Bayer's mega merger with Monsanto affect its pharmaceutical business?
9th November 2016
The US election and pharma
Where do the two candidates stand on pharma and how could it affect the industry?
11th October 2016
Making precision medicine work
Cancer Research UK's head of precision medicine on how the charity is preparing the NHS for this paradigm shift in treatment
15th August 2016
Inclusion criteria
With new research showing that pharma senior teams are less diverse than comparable industries, companies could do more to instil a culture of inclusion
3rd August 2016
Now it's personal
Putting the right tools in patients' hands could personalise treatment and improve health across the board
29th July 2016
Industry roundup – 21 July
Biobank banks genes of long-lived Sardinians; stem cell therapies face commercial challenges; VBI moves forward with Zika Vaccine
21st July 2016
A rare discovery
In rare diseases, the story of a drug's development is often an intensely personal one for the scientists, patient groups and, of course, patients. However, few of those personal stories have been made into a Hollywood movie. Meet John Crowley, chairman and CEO of rare disease company, Amicus Therapeutics
18th July 2016
Industry roundup – 14 July
Boehringer seeks novel protein-destroying drugs; Study shows success of HIV treatment; Janssen gets Priority Review for WHO-recommended treatment
14th July 2016
Do patients know best?
A look at the platform that's putting medical information in the hands of patients
13th July 2016
